SVYSF - Solvay SA

Other OTC - Other OTC Delayed price. Currency in USD
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
16,071,000
16,071,000
11,435,000
9,714,000
11,227,000
Cost of revenue
12,042,000
12,042,000
8,508,000
7,207,000
8,244,000
Gross profit
4,029,000
4,029,000
2,927,000
2,507,000
2,983,000
Operating expenses
Research development
357,000
357,000
325,000
300,000
323,000
Selling general and administrative
1,405,000
1,405,000
1,233,000
1,212,000
1,331,000
Total operating expenses
1,908,000
1,908,000
1,650,000
1,663,000
1,796,000
Operating income or loss
2,121,000
2,121,000
1,277,000
844,000
1,187,000
Interest expense
118,000
118,000
107,000
191,000
261,000
Income before tax
2,151,000
2,151,000
1,094,000
-844,000
74,000
Income tax expense
217,000
217,000
110,000
248,000
153,000
Income from continuing operations
1,934,000
1,934,000
985,000
-1,092,000
-79,000
Net income
1,905,000
1,905,000
948,000
-962,000
118,000
Net income available to common shareholders
1,905,000
1,905,000
948,000
-962,000
118,000
Basic EPS
-
18.37
9.15
-9.32
1.15
Diluted EPS
-
18.30
9.13
-9.32
1.15
Basic average shares
-
103,744
103,527
103,140
103,177
Diluted average shares
-
104,143
103,788
103,170
103,403
EBITDA
-
3,192,000
2,050,000
363,000
1,367,000